Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
16.60B | 66.68B | 64.61B | 50.61B | 45.06B | 45.27B | Gross Profit |
2.78B | 10.54B | 11.35B | 8.64B | 8.68B | 7.36B | EBIT |
641.00M | 2.56B | 3.54B | 1.50B | 1.52B | 12.00M | EBITDA |
1.30B | 5.69B | 6.02B | 4.08B | 3.88B | 2.42B | Net Income Common Stockholders |
570.00M | 2.43B | 2.60B | 1.37B | 1.23B | 238.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.10B | 214.00M | 411.00M | 198.00M | 177.00M | 221.00M | Total Assets |
43.03B | 46.43B | 46.50B | 39.69B | 36.22B | 34.68B | Total Debt |
11.71B | 7.90B | 10.99B | 7.49B | 4.90B | 6.64B | Net Debt |
9.61B | 7.69B | 10.58B | 7.29B | 4.72B | 6.42B | Total Liabilities |
22.43B | 22.10B | 23.81B | 18.64B | 16.30B | 15.97B | Stockholders Equity |
20.59B | 24.33B | 22.70B | 21.05B | 19.93B | 18.70B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.72B | -3.13B | -2.38B | 2.27B | -500.00M | Operating Cash Flow |
0.00 | 6.77B | -533.00M | 292.00M | 3.85B | 2.46B | Investing Cash Flow |
0.00 | -2.46B | -2.24B | -2.41B | -2.12B | -2.98B | Financing Cash Flow |
0.00 | -4.51B | 2.98B | 2.14B | -1.78B | 516.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥16.08B | 10.53 | 2.91% | -5.97% | -37.27% | ||
71 Outperform | ¥13.91B | 15.00 | 1.80% | 4.25% | -18.59% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
64 Neutral | ¥14.43B | 17.26 | 1.53% | 0.59% | -15.61% | ||
61 Neutral | ¥14.23B | 25.73 | 1.95% | 4.72% | 20.48% | ||
57 Neutral | ¥13.36B | 38.02 | 2.43% | 1.59% | -57.66% | ||
56 Neutral | ¥13.34B | 25.04 | 0.31% | -2.04% | ― |